ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $19,887,002 | +145.2% | 830,355 | +92.7% | 0.24% | +114.5% |
| Q1 2023 | $8,109,632 | +25.3% | 430,905 | +8.9% | 0.11% | +22.2% |
| Q3 2022 | $6,471,000 | +76.7% | 395,549 | +52.2% | 0.09% | +60.7% |
| Q2 2022 | $3,663,000 | -62.3% | 259,967 | -37.5% | 0.06% | -59.7% |
| Q4 2021 | $9,714,000 | -0.7% | 416,200 | -29.3% | 0.14% | -13.1% |
| Q3 2021 | $9,781,000 | -39.5% | 588,859 | -11.2% | 0.16% | -47.0% |
| Q2 2021 | $16,172,000 | +60.5% | 663,054 | +69.8% | 0.30% | +34.8% |
| Q1 2021 | $10,077,000 | +270.2% | 390,591 | +667.2% | 0.22% | +211.1% |
| Q4 2020 | $2,722,000 | -79.8% | 50,913 | -84.5% | 0.07% | -83.7% |
| Q3 2020 | $13,506,000 | +352.5% | 327,415 | +431.7% | 0.44% | +275.4% |
| Q2 2020 | $2,985,000 | – | 61,575 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |